Our Insights
Deep dive into critically written articles by cardiologists, unpacking the complexities and perspectives of cardiometabolics.
Beyond the Diagnosis. Think Deeper.
CardioAdvocate Insights go beyond individual conditions — editorials, practical guides, lifestyle deep-dives, and the science shaping the future of heart care. Written for patients and families who want to understand the bigger picture.
Editorials & Analysis (2 articles)
Conference Coverage (1 article)
Practical Guides (3 articles)
Science & Innovation (5 articles)
Lifestyle & Wellness (4 articles)
Getting Started (2 articles)
Victims of Our Own Success
The first Lp(a)-lowering outcomes trial missed its mark. But a negative result in patients already on the best therapy the world has ever offered isn’t the same thing as a disproven hypothesis. The Lp(a) story has a next chapter.
Red Red Wine, Stay Close to Me
What does the science actually say about alcohol and your heart? The answer is more nuanced than you’ve been told. From the French Paradox to modern Mendelian randomization studies, we separate myth from evidence on red wine, polyphenols, and cardiovascular health.
The Accidental Cardioprotectors
How Diabetes Drugs Became Heart Drugs — and Why That Changes Everything
Rewriting the Code
From Tragedy to Triumph — The Promise and Peril of Gene Editing in Medicine
ACC 2026: CardioAdvocate Take
ACC 2026 Late-Breaking Trials: CardioAdvocate’s Take on What Changed for Your Heart
Breaking the Loop: The Cholesterol-Inflammation Fusion Hypothesis and What It Means for Your Heart
Time to revisit the REDUCE-IT and JUPITER trials? Are there multiple phenotypes of inflammation?
Step in the Right Direction: The 2026 ACC/AHA Cholesterol Guidelines
Time to revisit the REDUCE-IT and JUPITER trials? Are there multiple phenotypes of inflammation?
A Cup of Joe Never Hurt Anyone
Shining a light on more than just “industry bias” in medicine
Who Needs to See a Cardiologist/Cardiometabolic Specialist?
If you’ve never seen a cardiologist or cardiometabolic specialist and are wondering if you should, this guide is for you.
The Wild, Wild West
How the Supplement Industry Profits From Regulatory Loopholes, Drug-Like Products, and Deceptive Marketing
CardioConundrums
A case-based way to learn about the nuances of cardiometabolic diseases with an interactive Q and A Forum
What’s Your ApoB?
Why is everyone talking about ApoB? Are subfractions important? A practical approach to lipid biomarkers.